Elevance Health, Inc. (ELV) operating KPIs
ELVNYSEHospital & Medical Service PlansFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Oct 21, 2026Score 15/3012% below fair value
$420.07−1.95 (-0.46%)
Close on Oct 30, 2026Market cap $91.10BP/E 18.7Yield –
Elevance Health gAAP Pretax Income Margin (% of Total Revenue) (%)
Quarterly figures from Elevance Health's filings and investor materials
Latest, Q3 2026
3.5%
Period ended Sep 30, 2026
Change on a year earlier
+0.7 pts
2.8% in Q3 2025
History
36 quarters
Since Q1 2017
Sources
32
Documents cited below
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | GAAP Pretax Income Margin (% of Total Revenue) (%) | Year on year | Source |
|---|---|---|---|---|
| Q3 2026 | Sep 30, 2026 | 3.5% | +0.7 pts | 8-K ER (FY2026Q3, 2026-10-21) ↗ |
| Q2 2026 | Jun 30, 2026 | 3.8% | -0.8 pts | 8-K ER (FY2026Q2, 2026-07-15) ↗ |
| Q1 2026 | Mar 31, 2026 | 4.6% | -1.1 pts | 8-K ER (FY2026Q1, 2026-04-22) ↗ |
| Q4 2025 | Dec 31, 2025 | 0.4% | -0.9 pts | 8-K ER (FY2025Q4, 2026-01-28) ↗ |
| Q3 2025 | Sep 30, 2025 | 2.8% | -0.2 pts | 8-K ER (FY2026Q3, 2026-10-21) ↗ |
| Q2 2025 | Jun 30, 2025 | 4.6% | -2.2 pts | 8-K ER (FY2026Q2, 2026-07-15) ↗ |
| Q1 2025 | Mar 31, 2025 | 5.7% | -1.2 pts | 8-K ER (FY2026Q1, 2026-04-22) ↗ |
| Q4 2024 | Dec 31, 2024 | 1.3% | -1.0 pts | 8-K ER (FY2025Q4, 2026-01-28) ↗ |
| Q3 2024 | Sep 30, 2024 | 3.0% | -0.9 pts | 8-K ER (FY2025Q3, 2025-10-21) ↗ |
| Q2 2024 | Jun 30, 2024 | 6.8% | +1.2 pts | 8-K ER (FY2025Q2, 2025-07-17) ↗ |
| Q1 2024 | Mar 31, 2024 | 6.9% | +0.7 pts | 8-K ER (FY2025Q1, 2025-04-22) ↗ |
| Q4 2023 | Dec 31, 2023 | 2.3% | -0.3 pts | 8-K ER (FY2024Q4, 2025-01-23) ↗ |
| Q3 2023 | Sep 30, 2023 | 3.9% | -1.7 pts | 8-K ER (FY2024Q3, 2024-10-17) ↗ |
| Q2 2023 | Jun 30, 2023 | 5.6% | -0.2 pts | 8-K ER (FY2024Q2, 2024-07-17) ↗ |
| Q1 2023 | Mar 31, 2023 | 6.2% | +0.1 pts | 8-K ER (FY2024Q1, 2024-04-18) ↗ |
| Q4 2022 | Dec 31, 2022 | 2.6% | -1.2 pts | 8-K ER (FY2023Q4, 2024-01-24) ↗ |
| Q3 2022 | Sep 30, 2022 | 5.6% | -0.8 pts | 8-K ER (FY2023Q3, 2023-10-18) ↗ |
| Q2 2022 | Jun 30, 2022 | 5.8% | -1.0 pts | 8-K ER (FY2023Q2, 2023-07-19) ↗ |
| Q1 2022 | Mar 31, 2022 | 6.1% | -0.6 pts | 8-K ER (FY2023Q1, 2023-04-19) ↗ |
| Q4 2021 | Dec 31, 2021 | 3.8% | +1.9 pts | 8-K ER (FY2022Q4, 2023-01-25) ↗ |
| Q3 2021 | Sep 30, 2021 | 6.4% | +0.2 pts | 8-K ER (FY2022Q3, 2022-10-19) ↗ |
| Q2 2021 | Jun 30, 2021 | 6.8% | -4.0 pts | 8-K ER (FY2022Q2, 2022-07-20) ↗ |
| Q1 2021 | Mar 31, 2021 | 6.7% | -0.4 pts | 10-Q (2022-04-20) ↗ |
| Q4 2020 | Dec 31, 2020 | 1.9% | – | 8-K ER (FY2021Q4, 2022-01-26) ↗ |
| Q3 2020 | Sep 30, 2020 | 6.2% | +0.6 pts | 8-K ER (FY2021Q3, 2021-10-20) ↗ |
| Q2 2020 | Jun 30, 2020 | 10.8% | +5.1 pts | 10-Q (2021-07-21) ↗ |
| Q1 2020 | Mar 31, 2020 | 7.1% | -0.8 pts | 10-Q (2021-04-21) ↗ |
| Q3 2019 | Sep 30, 2019 | 5.6% | +0.3 pts | 10-Q (2020-10-28) ↗ |
| Q2 2019 | Jun 30, 2019 | 5.7% | -0.9 pts | 10-Q (2020-07-29) ↗ |
| Q1 2019 | Mar 31, 2019 | 7.9% | 0.0 pts | 10-Q (2020-04-29) ↗ |
| Q3 2018 | Sep 30, 2018 | 5.3% | +0.3 pts | 10-Q (2019-10-23) ↗ |
| Q2 2018 | Jun 30, 2018 | 6.6% | +1.2 pts | 10-Q (2019-07-24) ↗ |
| Q1 2018 | Mar 31, 2018 | 7.9% | +1.2 pts | 10-Q (2019-04-24) ↗ |
| Q3 2017 | Sep 30, 2017 | 5.0% | – | 10-Q (2018-10-31) ↗ |
| Q2 2017 | Jun 30, 2017 | 5.4% | – | 10-Q (2018-07-25) ↗ |
| Q1 2017 | Mar 31, 2017 | 6.7% | – | 10-Q (2018-04-25) ↗ |
Cite this data
StockData. (2026). Elevance Health GAAP Pretax Income Margin (% of Total Revenue) (%), quarterly Q1 2017–Q3 2026 [Data set]. Compiled from Elevance Health SEC filings and investor materials. https://stockdatahq.com/stocks/elv/kpis/ratio_pretax_margin_gaap
See every metric in the Elevance Health KPI table. Data updated Oct 28, 2026.